Emily Y Huang

Ms. Emily Y Huang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2019 in Diabetes
Verified
Journal Article
Closed access
PDF file
CRCandace M. Reno
Candace M. Reno
JBJustin Bayles
Justin Bayles
EHEmily Y Huang
Emily Y Huang
MOMilan Oxspring
Milan Oxspring
AHAnnie M. Hirahara
Annie M. Hirahara
SFSimon J. Fisher
Simon J. Fisher
The contribution of the sympathetic nervous system (SNS) versus the parasympathetic nervous system (PSNS) in mediating fatal cardiac arrhythmias during insulin-induced severe hypoglycemia is not well understood. Therefore, experimental protocols were performed in nondiabetic Sprague-Dawley rats to test the SNS with 1) adrenal demedullation and 2) chemical sympathectomy, and to test the PSNS with 3) surgical vagotomy, 4) nicotinic receptor (mecamylamine) and muscarinic receptor (AQ-RA 741) blockade, and 5) ex vivo heart perfusions with normal or low glucose, acetylcholine (ACh), and/or mecamylamine. In protocols 1–4, 3-h hyperinsulinemic (0.2 units/kg/min) and hypoglycemic (10–15 mg/dL) clamps were performed. Adrenal demedullation and chemical sympathectomy had no effect on mortality or arrhythmias during severe hypoglycemia compared with controls. Vagotomy led to a 6.9-fold decrease in mortality; reduced first- and second-degree heart block 4.6- and 4-fold, respectively; and prevented third-degree heart block compared with controls. Pharmacological blockade of nicotinic receptors, but not muscarinic receptors, prevented heart block and mortality versus controls. Ex vivo heart perfusions demonstrated that neither low glucose nor ACh alone caused arrhythmias, but their combination induced heart block that could be abrogated by nicotinic receptor blockade. Taken together, ACh activation of nicotinic receptors via the vagus nerve is the primary mediator of severe hypoglycemia–induced fatal cardiac arrhythmias.

15 March 2022 in American Journal of Infection Control
Verified
Journal Article
Closed access
CNChristopher Nielson
Christopher Nielson
DSDaniel Suarez
Daniel Suarez
ITIsabel Taylor
Isabel Taylor
EHEmily Y Huang
Emily Y Huang
APAlbert Park
Albert Park

25 March 2024 in The Laryngoscope
Verified
Journal Article
Closed access
RSRaymond So
Raymond So
CRChristopher Rayle
Christopher Rayle
HJHenry H. Joo
Henry H. Joo
EHEmily Y Huang
Emily Y Huang
TSTanguy Y. Seiwert
Tanguy Y. Seiwert
SBSimon R. Best
Simon R. Best

21 September 2023 in Sinusitis
Verified
Journal Article
Open access
PDF file
CDCamron Davies
Camron Davies
FWFranklin Wu
Franklin Wu
EHEmily Y Huang
Emily Y Huang
MTMasayoshi Takashima
Masayoshi Takashima
Nicholas RowanNicholas Rowan
Nicholas Rowan
OAOmar Gasudraz Ahmed
Omar Gasudraz Ahmed
Central compartment atopic disease (CCAD) is a distinct phenotype within chronic rhinosinusitis with nasal polyps (CRSwNP) with a pathophysiology that bridges the gap between allergy and CRSwNP, an association that was previously ambiguous. Understanding this endotype and its link to allergic disease is crucial for improved CCAD management. Using a systematic search and an independent dual-reviewer evaluation and data extraction process, this scoping review examines the clinical features, management options, and treatment outcomes of CCAD. Central compartment (CC) polypoid changes of the MT predominantly correlate with allergic rhinitis, increased septal inflammation, oblique MT orientation, and decreased nasal cavity opacification and Lund–Mackay scores compared to other CRSwNP subtypes. CCAD patients also exhibit higher rates of asthma, allergen sensitization, and hyposmia or anosmia. Surgical outcomes, including revision rate and SNOT-22 improvement, are favorable in CCAD as well. In conclusion, CCAD primarily affects atopic individuals and is managed using endoscopic sinus surgery combined with treating the underlying allergy. Continued research is needed to further refine understanding and develop optimal treatment strategies of this emerging CRS subtype.

1 June 2020 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
CNChristopher Nielson
Christopher Nielson
EHEmily Y Huang
Emily Y Huang
CKC. Amanda Kull
C. Amanda Kull
APAlbert Park
Albert Park

1 November 2022 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
CRCandace M Reno-Bernstein
Candace M Reno-Bernstein
MOMilan Oxspring
Milan Oxspring
JBJustin Bayles
Justin Bayles
EHEmily Y Huang
Emily Y Huang
IHIvana Holiday
Ivana Holiday
SFSimon J. Fisher
Simon J. Fisher
For people with type 1 diabetes, severe hypoglycemia can be fatal. We show in our animal model that insulin-deficient diabetic rats have fatal cardiac arrhythmias during severe hypoglycemia that are associated with increased cardiac oxidative stress. Importantly, treatment with vitamin E, to reduce oxidative stress, decreased fatal cardiac arrhythmias during severe hypoglycemia.